The company says this unique salmon oil concentrate is the firm’s answer to “the low omega-3 content found in traditional salmon oils.”
GC Rieber Oils (Montclair, NJ), a supplier of refined fish oils, announced the North American launch of its new pure salmon oil concentrate. The company says this unique salmon oil concentrate is the firm’s answer to “the low omega-3 content found in traditional salmon oils.”
By contrast, it says, its pure salmon oil concentrate has been formulated to provide a total omega-3 content containing a minimum 460 mg/g as triglyceride-over twice the omega-3 content of traditional salmon oil, it says. In addition, the concentrate is said to contain higher levels of omega-3 fatty acid DPA (a minimum of 40 mg/g). DPA is an intermediary between EPA and DHA omega-3 fatty acids.
The salmon oil is sourced from fjord-farmed salmon, for which the company says there is 100% traceability. The oil is said to be fresh and stable, without a fishy taste or smell.
“The pure salmon oil concentrate is our newest innovation to reach the market,” says Steve Dillingham, general manager, GC Rieber Oils Inc. “[It] comes on the heels of our VivoMega 70 DHA Ultra launch late last year. The market response to our 70 DHA Ultra has been extremely encouraging, and we believe that our new pure salmon oil concentrate will be equally well received due to its uniqueness in the market.”
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.